Researchers at University of Chicago are looking at the use of Depade (naltrexone) as a smoking cessation tool, and the news appears to be good for women in particular.
As reported in the October 2006 issue of the journal Nicotine and Tobacco Research, women using a combination of Depade, NRT's and behavioral therapy may improve their rate of success by 50 percent when quitting smoking. Typical weight gain associated with early smoking cessation was also reduced, but these benefits appeared not to affect men.
"Women have historically had less success than men in giving up cigarettes," said study author Andrea King, Ph.D., associate professor of psychiatry at the University of Chicago. "In this small study, naltrexone seems to have closed that gap."
Researchers are now looking at the effects of using naltrexone for smoking cessation over a longer span of time. For more on this ongoing clinical trial, visit Clinical Trials.gov
As reported in the October 2006 issue of the journal Nicotine and Tobacco Research, women using a combination of Depade, NRT's and behavioral therapy may improve their rate of success by 50 percent when quitting smoking. Typical weight gain associated with early smoking cessation was also reduced, but these benefits appeared not to affect men.
"Women have historically had less success than men in giving up cigarettes," said study author Andrea King, Ph.D., associate professor of psychiatry at the University of Chicago. "In this small study, naltrexone seems to have closed that gap."
Researchers are now looking at the effects of using naltrexone for smoking cessation over a longer span of time. For more on this ongoing clinical trial, visit Clinical Trials.gov
Wow, T! This sounds VERY promising! Amazing! Thanks for all you do to keep us up to date on the latest!